The biotech world is a prime target for risk-tolerant investors seeking out companies with the potential for dramatic gains. Firms in this space often either make it big—spiking upon news of a ...

According to TipRanks.com, Blum is a 5-star analyst with an average return of 14.1% and a 44.6% success rate. Blum covers the Healthcare sector, focusing on stocks such as Artiva Biotherapeutics, Inc.

The last time I spoke about Absci Corporation (ABSI), it was in a Seeking Alpha article entitled "Absci: AI-Driven Platform Could Establish Best-In-Class TL1A Drug Targeting Profile." The hope here ...

Absci Corp (NASDAQ:ABSI) shares are trading lower by 9.4% to $4.46 Wednesday afternoon after the company announced an offering of 16.7 million shares at $4.50 per share. The underwriters have an ...